IYH holdings
iShares U.S. Healthcare ETF
Positions
103 stored of 103 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY AND COMPANY ELI LILLY CO | US5324571083 | 532457108 | 15.106% | $538.2M | Equity (common) | Corporate | United States | USD |
| 2 | JOHNSON & JOHNSON | US4781601046 | 478160104 | 10.174% | $362.5M | Equity (common) | Corporate | United States | USD |
| 3 | ABBVIE INC. | US00287Y1091 | 00287Y109 | 7.318% | $260.7M | Equity (common) | Corporate | United States | USD |
| 4 | UNITEDHEALTH GROUP INCORPORATED | US91324P1021 | 91324P102 | 6.163% | $219.6M | Equity (common) | Corporate | United States | USD |
| 5 | MERCK & CO., INC. | US58933Y1055 | 58933Y105 | 5.305% | $189.0M | Equity (common) | Corporate | United States | USD |
| 6 | THERMO FISHER SCIENTIFIC INCORPORATED | US8835561023 | 883556102 | 3.516% | $125.3M | Equity (common) | Corporate | United States | USD |
| 7 | AMGEN INC. | US0311621009 | 031162100 | 3.424% | $122.0M | Equity (common) | Corporate | United States | USD |
| 8 | ABBOTT LABORATORIES | US0028241000 | 002824100 | 3.017% | $107.5M | Equity (common) | Corporate | United States | USD |
| 9 | GILEAD SCIENCES, INC. | US3755581036 | 375558103 | 2.664% | $94.9M | Equity (common) | Corporate | United States | USD |
| 10 | PFIZER INC. | US7170811035 | 717081103 | 2.346% | $83.6M | Equity (common) | Corporate | United States | USD |
| 11 | BRISTOL-MYERS SQUIBB COMPANY | US1101221083 | 110122108 | 2.197% | $78.3M | Equity (common) | Corporate | United States | USD |
| 12 | INTUITIVE SURGICAL, INC. | US46120E6023 | 46120E602 | 2.051% | $73.1M | Equity (common) | Corporate | United States | USD |
| 13 | DANAHER CORPORATION | US2358511028 | 235851102 | 2.030% | $72.3M | Equity (common) | Corporate | United States | USD |
| 14 | VERTEX PHARMACEUTICALS INCORPORATED | US92532F1003 | 92532F100 | 1.998% | $71.2M | Equity (common) | Corporate | United States | USD |
| 15 | STRYKER CORPORATION | US8636671013 | 863667101 | 1.856% | $66.1M | Equity (common) | Corporate | United States | USD |
| 16 | MEDTRONIC PUBLIC LIMITED COMPANY MEDTRONIC PLC | IE00BTN1Y115 | G5960L103 | 1.804% | $64.3M | Equity (common) | Corporate | Ireland | USD |
| 17 | ELEVANCE HEALTH, INC. | US0367521038 | 036752103 | 1.344% | $47.9M | Equity (common) | Corporate | United States | USD |
| 18 | REGENERON PHARMACEUTICALS, INC. | US75886F1075 | 75886F107 | 1.270% | $45.2M | Equity (common) | Corporate | United States | USD |
| 19 | THE CIGNA GROUP CIGNA GROUP THE | US1255231003 | 125523100 | 1.200% | $42.8M | Equity (common) | Corporate | United States | USD |
| 20 | BOSTON SCIENTIFIC CORPORATION | US1011371077 | 101137107 | 1.141% | $40.7M | Equity (common) | Corporate | United States | USD |
| 21 | HCA HEALTHCARE, INC. | US40412C1018 | 40412C101 | 0.990% | $35.3M | Equity (common) | Corporate | United States | USD |
| 22 | EDWARDS LIFESCIENCES CORPORATION | US28176E1082 | 28176E108 | 0.808% | $28.8M | Equity (common) | Corporate | United States | USD |
| 23 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | US0669225197 | 066922519 | 0.799% | $28.5M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 24 | BECTON, DICKINSON AND COMPANY BECTON DICKINSON CO | US0758871091 | 075887109 | 0.775% | $27.6M | Equity (common) | Corporate | United States | USD |
| 25 | IDEXX LABORATORIES, INC. | US45168D1046 | 45168D104 | 0.727% | $25.9M | Equity (common) | Corporate | United States | USD |
| 26 | HUMANA INC. | US4448591028 | 444859102 | 0.720% | $25.7M | Equity (common) | Corporate | United States | USD |
| 27 | IQVIA HOLDINGS INC | US46266C1053 | 46266C105 | 0.644% | $23.0M | Equity (common) | Corporate | United States | USD |
| 28 | AGILENT TECHNOLOGIES, INC. | US00846U1016 | 00846U101 | 0.644% | $22.9M | Equity (common) | Corporate | United States | USD |
| 29 | WATERS CORPORATION | US9418481035 | 941848103 | 0.611% | $21.8M | Equity (common) | Corporate | United States | USD |
| 30 | NATERA, INC. | US6323071042 | 632307104 | 0.602% | $21.5M | Equity (common) | Corporate | United States | USD |
| 31 | REVOLUTION MEDICINES, INC. | US76155X1000 | 76155X100 | 0.591% | $21.1M | Equity (common) | Corporate | United States | USD |
| 32 | ZOETIS INC. | US98978V1035 | 98978V103 | 0.536% | $19.1M | Equity (common) | Corporate | United States | USD |
| 33 | DEXCOM, INC. | US2521311074 | 252131107 | 0.527% | $18.8M | Equity (common) | Corporate | United States | USD |
| 34 | ILLUMINA, INC. | US4523271090 | 452327109 | 0.513% | $18.3M | Equity (common) | Corporate | United States | USD |
| 35 | GE HEALTHCARE TECHNOLOGIES INC. | US36266G1076 | 36266G107 | 0.509% | $18.1M | Equity (common) | Corporate | United States | USD |
| 36 | CENTENE CORPORATION | US15135B1017 | 15135B101 | 0.506% | $18.0M | Equity (common) | Corporate | United States | USD |
| 37 | RESMED INC. | US7611521078 | 761152107 | 0.505% | $18.0M | Equity (common) | Corporate | United States | USD |
| 38 | VEEVA SYSTEMS INC. | US9224751084 | 922475108 | 0.501% | $17.9M | Equity (common) | Corporate | United States | USD |
| 39 | BIOGEN INC. | US09062X1037 | 09062X103 | 0.493% | $17.6M | Equity (common) | Corporate | United States | USD |
| 40 | ALNYLAM PHARMACEUTICALS, INC. | US02043Q1076 | 02043Q107 | 0.451% | $16.1M | Equity (common) | Corporate | United States | USD |
| 41 | QUEST DIAGNOSTICS INCORPORATED | US74834L1008 | 74834L100 | 0.424% | $15.1M | Equity (common) | Corporate | United States | USD |
| 42 | LABCORP HOLDINGS INC. | US5049221055 | 504922105 | 0.418% | $14.9M | Equity (common) | Corporate | United States | USD |
| 43 | ROYALTY PHARMA PLC | GB00BMVP7Y09 | G7709Q104 | 0.398% | $14.2M | Equity (common) | Corporate | United Kingdom | USD |
| 44 | WEST PHARMACEUTICAL SERVICES, INC. | US9553061055 | 955306105 | 0.392% | $14.0M | Equity (common) | Corporate | United States | USD |
| 45 | STERIS PUBLIC LIMITED COMPANY STERIS PLC | IE00BFY8C754 | G8473T100 | 0.368% | $13.1M | Equity (common) | Corporate | Ireland | USD |
| 46 | TENET HEALTHCARE CORPORATION | US88033G4073 | 88033G407 | 0.358% | $12.8M | Equity (common) | Corporate | United States | USD |
| 47 | UNITED THERAPEUTICS CORPORATION | US91307C1027 | 91307C102 | 0.353% | $12.6M | Equity (common) | Corporate | United States | USD |
| 48 | INSMED INCORPORATED | US4576693075 | 457669307 | 0.348% | $12.4M | Equity (common) | Corporate | United States | USD |
| 49 | GUARDANT HEALTH, INC. | US40131M1099 | 40131M109 | 0.340% | $12.1M | Equity (common) | Corporate | United States | USD |
| 50 | VIATRIS INC. | US92556V1061 | 92556V106 | 0.336% | $12.0M | Equity (common) | Corporate | United States | USD |
| 51 | MODERNA, INC. | US60770K1079 | 60770K107 | 0.329% | $11.7M | Equity (common) | Corporate | United States | USD |
| 52 | INCYTE CORPORATION | US45337C1027 | 45337C102 | 0.326% | $11.6M | Equity (common) | Corporate | United States | USD |
| 53 | ZIMMER BIOMET HOLDINGS, INC. | US98956P1021 | 98956P102 | 0.300% | $10.7M | Equity (common) | Corporate | United States | USD |
| 54 | MEDLINE INC. | US58507V1070 | 58507V107 | 0.290% | $10.3M | Equity (common) | Corporate | United States | USD |
| 55 | Roivant Sciences Ltd | BMG762791017 | G76279101 | 0.273% | $9.7M | Equity (common) | Corporate | Bermuda | USD |
| 56 | NEUROCRINE BIOSCIENCES, INC. | US64125C1099 | 64125C109 | 0.272% | $9.7M | Equity (common) | Corporate | United States | USD |
| 57 | JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY JAZZ PHARMACEUTICALS PLC | IE00B4Q5ZN47 | G50871105 | 0.249% | $8.9M | Equity (common) | Corporate | Ireland | USD |
| 58 | THE COOPER COMPANIES, INC. COOPER COS INC THE | US2166485019 | 216648501 | 0.233% | $8.3M | Equity (common) | Corporate | United States | USD |
| 59 | BRIDGEBIO PHARMA, INC. | US10806X1028 | 10806X102 | 0.223% | $7.9M | Equity (common) | Corporate | United States | USD |
| 60 | BAXTER INTERNATIONAL INC. | US0718131099 | 071813109 | 0.221% | $7.9M | Equity (common) | Corporate | United States | USD |
| 61 | MEDPACE HOLDINGS, INC. | US58506Q1094 | 58506Q109 | 0.219% | $7.8M | Equity (common) | Corporate | United States | USD |
| 62 | EXELIXIS, INC. | US30161Q1040 | 30161Q104 | 0.218% | $7.8M | Equity (common) | Corporate | United States | USD |
| 63 | ELANCO ANIMAL HEALTH INCORPORATED | US28414H1032 | 28414H103 | 0.214% | $7.6M | Equity (common) | Corporate | United States | USD |
| 64 | SOLVENTUM CORPORATION | US83444M1018 | 83444M101 | 0.208% | $7.4M | Equity (common) | Corporate | United States | USD |
| 65 | REVVITY, INC. | US7140461093 | 714046109 | 0.207% | $7.4M | Equity (common) | Corporate | United States | USD |
| 66 | PENUMBRA, INC. | US70975L1070 | 70975L107 | 0.200% | $7.1M | Equity (common) | Corporate | United States | USD |
| 67 | ASCENDIS PHARMA A/S | DK0060615755 | K08588103 | 0.200% | $7.1M | Equity (common) | Corporate | Denmark | USD |
| 68 | BIOMARIN PHARMACEUTICAL INC. | US09061G1013 | 09061G101 | 0.190% | $6.8M | Equity (common) | Corporate | United States | USD |
| 69 | INSULET CORPORATION | US45784P1012 | 45784P101 | 0.188% | $6.7M | Equity (common) | Corporate | United States | USD |
| 70 | ARROWHEAD PHARMACEUTICALS, INC. | US04280A1007 | 04280A100 | 0.188% | $6.7M | Equity (common) | Corporate | United States | USD |
| 71 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | US1598641074 | 159864107 | 0.188% | $6.7M | Equity (common) | Corporate | United States | USD |
| 72 | ALIGN TECHNOLOGY, INC. | US0162551016 | 016255101 | 0.187% | $6.6M | Equity (common) | Corporate | United States | USD |
| 73 | BIO-TECHNE CORPORATION | US09073M1045 | 09073M104 | 0.186% | $6.6M | Equity (common) | Corporate | United States | USD |
| 74 | ENCOMPASS HEALTH CORPORATION | US29261A1007 | 29261A100 | 0.180% | $6.4M | Equity (common) | Corporate | United States | USD |
| 75 | CORCEPT THERAPEUTICS INCORPORATED | US2183521028 | 218352102 | 0.179% | $6.4M | Equity (common) | Corporate | United States | USD |
| 76 | THE ENSIGN GROUP, INC. ENSIGN GROUP INC THE | US29358P1012 | 29358P101 | 0.166% | $5.9M | Equity (common) | Corporate | United States | USD |
| 77 | MOLINA HEALTHCARE, INC. | US60855R1005 | 60855R100 | 0.166% | $5.9M | Equity (common) | Corporate | United States | USD |
| 78 | HALOZYME THERAPEUTICS, INC. | US40637H1095 | 40637H109 | 0.160% | $5.7M | Equity (common) | Corporate | United States | USD |
| 79 | AXSOME THERAPEUTICS, INC. | US05464T1043 | 05464T104 | 0.155% | $5.5M | Equity (common) | Corporate | United States | USD |
| 80 | AVANTOR, INC. | US05352A1007 | 05352A100 | 0.150% | $5.4M | Equity (common) | Corporate | United States | USD |
| 81 | GLOBUS MEDICAL, INC. | US3795772082 | 379577208 | 0.145% | $5.2M | Equity (common) | Corporate | United States | USD |
| 82 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares BLACKROCK CASH FUNDS TREASURY | US0669224778 | 066922477 | 0.143% | $5.1M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 83 | UNIVERSAL HEALTH SERVICES, INC. | US9139031002 | 913903100 | 0.141% | $5.0M | Equity (common) | Corporate | United States | USD |
| 84 | IONIS PHARMACEUTICALS, INC. | US4622221004 | 462222100 | 0.140% | $5.0M | Equity (common) | Corporate | United States | USD |
| 85 | Qiagen N.V. QIAGEN NV COM | NL0015002SN0 | N72482156 | 0.140% | $5.0M | Equity (common) | Corporate | Netherlands | USD |
| 86 | HENRY SCHEIN, INC. | US8064071025 | 806407102 | 0.139% | $5.0M | Equity (common) | Corporate | United States | USD |
| 87 | MADRIGAL PHARMACEUTICALS, INC. | US5588681057 | 558868105 | 0.138% | $4.9M | Equity (common) | Corporate | United States | USD |
| 88 | DAVITA INC. | US23918K1088 | 23918K108 | 0.127% | $4.5M | Equity (common) | Corporate | United States | USD |
| 89 | REPLIGEN CORPORATION | US7599161095 | 759916109 | 0.124% | $4.4M | Equity (common) | Corporate | United States | USD |
| 90 | BRUKER CORPORATION | US1167941087 | 116794108 | 0.115% | $4.1M | Equity (common) | Corporate | United States | USD |
| 91 | CHEMED CORPORATION | US16359R1032 | 16359R103 | 0.114% | $4.0M | Equity (common) | Corporate | United States | USD |
| 92 | TELEFLEX INCORPORATED | US8793691069 | 879369106 | 0.100% | $3.6M | Equity (common) | Corporate | United States | USD |
| 93 | BIO-RAD LABORATORIES, INC. | US0905722072 | 090572207 | 0.097% | $3.5M | Equity (common) | Corporate | United States | USD |
| 94 | SOTERA HEALTH COMPANY | US83601L1026 | 83601L102 | 0.082% | $2.9M | Equity (common) | Corporate | United States | USD |
| 95 | TEMPUS AI, INC. | US88023B1035 | 88023B103 | 0.078% | $2.8M | Equity (common) | Corporate | United States | USD |
| 96 | ENVISTA HOLDINGS CORPORATION | US29415F1049 | 29415F104 | 0.073% | $2.6M | Equity (common) | Corporate | United States | USD |
| 97 | Viking Therapeutics Inc | US92686J1060 | 92686J106 | 0.059% | $2.1M | Equity (common) | Corporate | United States | USD |
| 98 | ORGANON & CO. | US68622V1061 | 68622V106 | 0.058% | $2.1M | Equity (common) | Corporate | United States | USD |
| 99 | Doximity Inc | US26622P1075 | 26622P107 | 0.046% | $1.6M | Equity (common) | Corporate | United States | USD |
| 100 | CARIS LIFE SCIENCES, INC. | US1421521071 | 142152107 | 0.032% | $1.1M | Equity (common) | Corporate | United States | USD |